“We believe we can apply this approach to any clinical trial. This will maximize our investment and enhance patient exposure to promising new compounds,” he concluded.
Disclosures: Dr. Merlo-Pich is a full-time employee of GlaxoSmithKline.
Placebo responses that are 'too high' or 'too low' generate noise within a randomized clinical trial.
Source DR. MERLO-PICH